GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (MIL:1AFX) » Definitions » Gross Profit

Carl Zeiss Meditec AG (MIL:1AFX) Gross Profit : €1,139 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Carl Zeiss Meditec AG Gross Profit?

Carl Zeiss Meditec AG's gross profit for the three months ended in Jun. 2024 was €293 Mil. Carl Zeiss Meditec AG's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was €1,139 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Carl Zeiss Meditec AG's gross profit for the three months ended in Jun. 2024 was €293 Mil. Carl Zeiss Meditec AG's Revenue for the three months ended in Jun. 2024 was €539 Mil. Therefore, Carl Zeiss Meditec AG's Gross Margin % for the quarter that ended in Jun. 2024 was 54.41%.

Carl Zeiss Meditec AG had a gross margin of 54.41% for the quarter that ended in Jun. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Carl Zeiss Meditec AG was 59.26%. The lowest was 51.89%. And the median was 55.65%.


Carl Zeiss Meditec AG Gross Profit Historical Data

The historical data trend for Carl Zeiss Meditec AG's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Gross Profit Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 831.88 745.52 967.21 1,127.60 1,205.77

Carl Zeiss Meditec AG Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 315.97 340.27 252.50 252.54 293.47

Competitive Comparison of Carl Zeiss Meditec AG's Gross Profit

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Gross Profit distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Gross Profit falls into.



Carl Zeiss Meditec AG Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Carl Zeiss Meditec AG's Gross Profit for the fiscal year that ended in Sep. 2023 is calculated as

Gross Profit (A: Sep. 2023 )=Revenue - Cost of Goods Sold
=2089.3 - 883.535
=1,206

Carl Zeiss Meditec AG's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=539.338 - 245.869
=293

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,139 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Carl Zeiss Meditec AG's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=293 / 539.338
=54.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Carl Zeiss Meditec AG  (MIL:1AFX) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Carl Zeiss Meditec AG had a gross margin of 54.41% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Carl Zeiss Meditec AG Gross Profit Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG Headlines

No Headlines